COSCIENS Biopharma Inc. (CSCIF) SEC Filings & Financial Intelligence
COSCIENS Biopharma Inc. (CSCIF) is a publicly traded company on the OTC, categorized under SIC 2844 (Perfumes, Cosmetics & Other Toilet Preparations). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: CSCIF
CIK: 1113423
Exchange: OTC
SIC 2844: Perfumes, Cosmetics & Other Toilet Preparations
Fiscal Year End: 12/31
State: A6
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Deloitte LLP
Auditor SinceSince 12/31/2023 12:00:00 AM
Lead Engagement PartnerDavid Pain
Audit LocationMontreal, Canada
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 15-12G | 2026-07-06 | — | 15-12G | 0001493152-26-032172 | View SEC Doc Filr Page |
| SC 13E3/A | 2026-07-06 | — | SC 13E3/A | 0001493152-26-032084 | View SEC Doc Filr Page |
| 6-K | 2026-07-06 | 2026-07-06 | 6-K | 0001493152-26-032085 | View SEC Doc Filr Page |
| SC 13E3/A | 2026-06-23 | — | SC 13E3/A | 0001493152-26-029667 | View SEC Doc Filr Page |
| 6-K | 2026-06-23 | 2026-06-22 | 6-K | 0001493152-26-029666 | View SEC Doc Filr Page |
| 6-K | 2026-06-18 | 2026-06-18 | 6-K | 0001493152-26-029205 | View SEC Doc Filr Page |
| SC 13E3/A | 2026-06-18 | — | SC 13E3/A | 0001493152-26-029198 | View SEC Doc Filr Page |
| SC 13E3/A | 2026-05-20 | — | SC 13E3/A | 0001493152-26-024635 | View SEC Doc Filr Page |
| 6-K | 2026-05-20 | 2026-05-20 | 6-K | 0001493152-26-024629 | View SEC Doc Filr Page |
| SC 13E3/A | 2026-05-12 | — | SC 13E3/A | 0001493152-26-022542 | View SEC Doc Filr Page |
| 6-K | 2026-05-12 | 2026-05-12 | 6-K | 0001493152-26-022524 | View SEC Doc Filr Page |
| 6-K | 2026-05-12 | 2026-03-31 | 6-K | 0001493152-26-022523 | View SEC Doc Filr Page |
| SC 13E3/A | 2026-05-08 | — | SC 13E3/A | 0001493152-26-022002 | View SEC Doc Filr Page |
| 6-K | 2026-05-08 | 2026-05-08 | 6-K | 0001493152-26-022001 | View SEC Doc Filr Page |
| SC 13E3/A | 2026-05-04 | — | SC 13E3/A | 0001493152-26-020983 | View SEC Doc Filr Page |
| SC 13E3 | 2026-04-20 | — | SC 13E3 | 0001493152-26-018001 | View SEC Doc Filr Page |
| 6-K | 2026-04-20 | 2026-04-20 | 6-K | 0001493152-26-018000 | View SEC Doc Filr Page |
| SCHEDULE 13D/A | 2026-04-17 | — | SCHEDULE 13D/A Filing | 0001493152-26-017950 | View SEC Doc Filr Page |
| 6-K | 2026-04-07 | 2026-04-07 | 6-K | 0001493152-26-015557 | View SEC Doc Filr Page |
| 20-F | 2026-03-25 | 2025-12-31 | 20-F | 0001493152-26-012703 | View SEC Doc Filr Page |
| 6-K | 2026-03-25 | 2026-03-25 | 6-K | 0001493152-26-012702 | View SEC Doc Filr Page |
| EFFECT | 2026-03-18 | — | EFFECT Filing | 9999999995-26-000852 | View SEC Doc Filr Page |
| EFFECT | 2026-03-18 | — | EFFECT Filing | 9999999995-26-000847 | View SEC Doc Filr Page |
| EFFECT | 2026-03-18 | — | EFFECT Filing | 9999999995-26-000845 | View SEC Doc Filr Page |
| EFFECT | 2026-03-18 | — | EFFECT Filing | 9999999995-26-000844 | View SEC Doc Filr Page |